Hostname: page-component-848d4c4894-xfwgj Total loading time: 0 Render date: 2024-06-27T21:46:59.504Z Has data issue: false hasContentIssue false
  • English
  • Français

Continuous amphetamine intoxication: an animal model of the acute psychotic episode

Published online by Cambridge University Press:  09 July 2009

Gaylord D. Ellison  and
Michael S. Eison
Gaylord D. Ellison*
Affiliation:
Department of Psychology, UCLA, Los Angeles, California, USA
Michael S. Eison
Affiliation:
Department of Psychology, UCLA, Los Angeles, California, USA
*
1Address for correspondence: Dr Gaylord D. Ellison, Department of Psychology, UCLA, 405 Hilgard Avenue, Los Angeles, CA 90024, USA.
Get access Rights & Permissions [Opens in a new window]

Synopsis

When amphetamines are administered to humans every few hours for several days, either during the ‘speed runs’ of addicts or in controlled laboratory settings, the psychosis which reliably results is similar to paranoid schizophrenia in a number of important aspects. This unique regimen of drug intake, which involves the continuous presence of stimulants over a prolonged period of time, can be simulated in animals using subcutaneously implanted slow-release silicone pellets containing d-amphetamine base. Monkeys and rats implanted with these pellets develop stages of behavioural alterations which are somewhat similar in sequence to those observed in humans who have received frequent doses of amphetamine. An initial period of hyperactivity and exploratory behaviour is followed by the gradual development of motor stereotypies which become virtually incessant. A period of relative inactivity then appears which is followed, at 4–5 days after pellet implantation, by a late stage. This final stage is characterized by ‘wet-dog’ shakes, parasitotic-like grooming episodes, and a variety of other forms of hallucinatory-like behaviour. At about the same time there are distinctive and partially irreversible alterations in dopaminergic innervations of the caudate nucleus, but not in mesolimbic dopamine innervation of the nucleus accumbens or in several other neurotransmitter systems. Continuous amphetamine administration may reproduce some aspects of the prolonged excitation which accompanies an acute psychotic episode and may be a fruitful model for the clarification of the dopamine theory of schizophrenia.

Type
Research Article
Information
Psychological Medicine , Volume 13 , Issue 4 , November 1983 , pp. 751 - 761
Copyright
Copyright © Cambridge University Press 1983

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Angrist, M. & Gershon, S. (1970). The phenomenology of experimentally induced amphetamine psychosis – preliminary observations. Biological Psychiatry 2, 95–107.Google ScholarPubMed
Angrist, B., Lee, H. K. & Gershon, S. (1974). The antagonism of amphetamine-induced symptomatology by a neuroleptic. American Journal of Psychiatry 131, 817–819.CrossRefGoogle ScholarPubMed
Bell, D. S. (1965). Comparison of amphetamine psychosis and schizophrenia. American Journal of Psychiatry 111, 701–707.CrossRefGoogle ScholarPubMed
Bell, D. S. (1973). The experimental reproduction of amphetamine psychosis. Archives of General Psychiatry 29, 35–40.CrossRefGoogle ScholarPubMed
Bowers, M. (1968). Pathogenesis of acute schizophrenic psychosis. Archives of General Psychiatry 19, 348.CrossRefGoogle ScholarPubMed
Connell, P. (1958). Amphetamine Psychosis. Maudsley Monographs No. 5. Oxford University Press: London.Google Scholar
Eison, M., Eison, A. S. & Ellison, G. (1981). The regional distribution of d-amphetamine and local glucose utilization in rat brain during continuous amphetamine administration. Experimental Brain Research 43, 281–288.Google ScholarPubMed
Ellinwood, E. H. Jr (1967). Amphetamine psychosis: I. Description of the individuals and process. Journal of Nervous and Mental Disease 144, 273–283.CrossRefGoogle Scholar
Ellinwood, E. H. Jr (1968). Amphetamine psychosis: II. Theoretical implications. Journal of Neuropsychiatry 4, 45–54.Google ScholarPubMed
Ellinwood, E. H. Jr & Kilbey, M. (1977). Chronic stimulant intoxication models of psychosis. In Animal Models in Psychiatry and Neurology (ed. Hanin, I. and Usdin, E.), pp. 61–74. Pergamon Press: Oxford.Google Scholar
Ellison, G. (1983). Phasic alterations in dopamine metabolites following continuous administration of amphetamines. Brain Research 268, 387–389.CrossRefGoogle Scholar
Ellison, G. & Morris, W. (1981). Opposed stages of continuous amphetamine administration: Parallel alterations in motor stereotypies and in vivo spiroperidol binding. European Journal of Pharmacology 74, 207–214.CrossRefGoogle Scholar
Ellison, G. & Ratan, R. (1982). The late stage following continuous amphetamine administration to rats is correlated with altered dopamine but not serotonin metabolism. Life Sciences 31, 771–777.CrossRefGoogle Scholar
Ellison, G., Eison, M. & Huberman, H. (1978 a). Stages of constant amphetamine intoxication: Delayed appearance of abnormal social behaviors in rat colonies. Psychopharmacology 56, 293–299.CrossRefGoogle ScholarPubMed
Ellison, G., Eison, M., Huberman, H. & Daniel, F. (1978 b). Structural and biochemical alterations in dopaminergic innervation of the caudate nucleus following continuous amphetamine administration. Science 201, 276–278.CrossRefGoogle Scholar
Ellison, G., Nielsen, E. B. & Lyon, M. (1981). Animal model of psychosis: Hallucinatory behaviors in monkeys during the late stage of continuous amphetamine intoxication. Journal of Psychiatric Research 16, 13–22.CrossRefGoogle ScholarPubMed
Fuller, R. & Hemrick-Luecke, S. (1980). Long-lasting depletion of striatal dopamine by a single injection of amphetamine in iprindole-treated rats. Science 209, 305–306.CrossRefGoogle ScholarPubMed
Gold, M. S. & Bowers, M. Jr (1978). Neurobiological vulnerability to low-dose amphetamine psychosis. American Journal of Psychiatry 135, 1546–1548.Google ScholarPubMed
Griffith, J. D., Cavanaugh, J., Held, J. & Oates, J. (1972). Dextroamphetamines: Evaluation of psychomimetric properties in man. Archives of General Psychiatry 26, 97–100.CrossRefGoogle Scholar
Hollister, L. E. (1968). Chemical Psychoses: LSD and Related Drugs. C. C. Thomas: Springfield, Ill.Google Scholar
Hotchkiss, A. & Gibb, J. (1980). Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. Journal of Pharmacology and Experimental Therapeutics 214, 257–262.Google ScholarPubMed
Howlett, D. R. & Nahorski, S. R. (1979). Acute and chronic amphetamine treatments modulate striatal dopamine receptor binding sites. Brain Research 161, 173–178.CrossRefGoogle ScholarPubMed
Huberman, H. S., Eison, M. S., Bryan, K. S. & Ellison, G. (1977). A slow-release pellet for chronic amphetamine administration. European Journal of Pharmacology 45, 237.CrossRefGoogle ScholarPubMed
Jacobs, B. L., Trulson, M.E. & Stern, W. C. (1976). An animal model for studying the actions of LSD and related hallucinogens. Science 194, 741–743.CrossRefGoogle ScholarPubMed
Klawans, H. L. & Margolin, D. I. (1975). Amphetamine-induced dopaminergic hypersensitivity in guinea pigs. Archives of General Psychiatry 32, 725–732.CrossRefGoogle ScholarPubMed
Kramer, J. C. (1969). Introduction to amphetamine abuse. Journal of Psychedelic Drugs 2, 8–13.CrossRefGoogle Scholar
Kramer, J. C., Gischman, V. & Littlefield, D. (1967). Amphetamine abuse: Pattern and effects of high doses taken intravenously. Journal of the American Medical Association 201, 89–93.Google ScholarPubMed
Levine, M.Hull, C., Garcia-Rill, E.Erinoff, E., Buchwald, N. & Heller, A. (1980). Long-term decreases in spontaneous firing of caudate neurons induced by amphetamine in cats. Brain Research 194, 263–268.CrossRefGoogle ScholarPubMed
Lyon, M. & Nielsen, E. (1979). Drug induced stereotypies and psychosis. In Psychopathology in Animals (ed. Keehn, J.), pp. 103–142. Academic Press: New York.Google Scholar
Nelson, L. & Ellison, G. (1978). Enhanced stereotypies after repeated injections but not continuous amphetamines. Neuropharmacology 17, 1081–1084.CrossRefGoogle Scholar
Nielsen, E., Lee, T. & Ellison, G. (1980 a). Following several days of continuous administration d-amphetamine acquires hallucinogen-like properties. Psychopharmacology 68, 197–200.CrossRefGoogle Scholar
Nielsen, E. B., Nielsen, M., Ellison, G. & Braestrup, C. (1980 b). Decreased spiroperidol and LSD binding in rat brain after continuous amphetamine. European Journal of Pharmacology 66,149–154.CrossRefGoogle ScholarPubMed
Nwanze, E. & Jonsson, G. (1981). Amphetamine neurotoxicity on dopamine nerve terminals in the caudate nucleus of mice. Neuroscience Letters 26, 163–168.CrossRefGoogle ScholarPubMed
Randrup, A. & Munkvad, I. (1974). Pharmacology and physiology of stereotyped behaviour. Journal of Psychiatric Research 11, 1–10.CrossRefGoogle Scholar
Ricaurte, G. A., Schuster, C. R. & Seiden, L. S. (1980). Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: A regional study. Brain Research 193, 153–163.CrossRefGoogle Scholar
Ridley, R., Baker, H., Owen, F., Cross, A. & Crow, T. (1982). Behavioral and biochemical effects of chronic amphetamine treatment in the vervet monkey. Psychopharmacology 78, 245–251.CrossRefGoogle ScholarPubMed
Schlemmer, R. F., Thompson, V. D. & Davis, J. M. (1977). Effect of hallucinogen, 5-methoxy-N, N-dimethyltryptamine on primate social behaviour. Communications in Psychopharmacology 1,105–118.Google Scholar
Segal, D. S. & Mandell, A. J. (1974). Long-term administration of d-amphetamine: progressive augmentation of motor activity and stereotypy. Pharmacology, Biochemistry and Behavior 2, 255–259.CrossRefGoogle ScholarPubMed
Slater, E. (1959). Amphetamine psychosis. British Medical Journal i, 488.CrossRefGoogle Scholar
Smith, R. C. (1969). The world of the Haight–Ashbury speed freak. Journal of Psychedelic Drugs 2, 77–83.CrossRefGoogle Scholar
Snyder, S. H., Bannerjee, S., Yamamura, H. & Greenberg, D. (1974). Drugs, neurotransmitters, and schizophrenia: phenothiazines, amphetamine, and enzymes synthesizing psychotomimetic drugs aid schizophrenia research. Science 184, 1243–1253.CrossRefGoogle Scholar
Steranka, L. & Sanders-Bush, E. (1980). Long-term effects of continuous exposure to amphetamine on brain dopamine concentration and synaptosomal uptake in mice. European Journal of Pharmacology 65, 439–443.CrossRefGoogle ScholarPubMed
Stevens, J. R. (1973). An anatomy of schizophrenia? Archives of General Psychiatry 29, 177–189.CrossRefGoogle ScholarPubMed
Templeton, G. & Spruiell, V. (1958). Methedrine interviews: clinical and Rorschach studies. Psychiatric Quarterly 32, 781–795.CrossRefGoogle ScholarPubMed
Trulson, M. & Jacobs, B. (1981). Long-term amphetamine treatment decreases brain serotonin metabolism: implications for theories of schizophrenia. Science 205, 1295–1297.CrossRefGoogle Scholar
Wyatt, R. (1978). Is there an endogenous amphetamine? A testable hypothesis of schizophrenia. In The Nature of Schizophrenia (ed. Wynne, L., Cromwell, R. and Matthysse, S.), pp. 116–125. Wiley & Sons: New York.Google Scholar
Young, D. & Scoville, W. B. (1938). Paranoid psychosis in narcolepsy and the possible danger of Benzedrine treatment. Medical Clinics of North America 22, 637–646.CrossRefGoogle Scholar